Background and Aims: Familial Hypercholesterolemia (FH) is a genetic disease characterized by premature Arteriosclerotic Cardiovascular Disease (ASCVD). Low Density Lipoproteins (LDLs) may be subdivided into two main fractions: large-buoyant (lbLDL) and small-dense (sdLDL) particles, with different metabolic behaviour and atherogenicity. In a similar manner High Density Lipoproteins (HDLs) may be separated into subpopulations of different size and composition. Aim of the present study is the evaluation of LDL and HDL subfractions in FH patients, tring to identify their predicting value in cardiovascular disease onset and the effects of lipid-lowering treatment.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
448 / #1063 Poster 2. LIPIDS AND LIPOPROTEINS / 2.3 HDL 10-05-2020 8:30 AM - 7:00 PM
© 2020 Published by Elsevier Inc.